Global Tizanidine Market Size, Share & Trends Analysis Report, By Type (2 mg and 4 mg), By Application (Kids and Adults), Forecast (2022-2028)

The global tizanidine market is anticipated to grow at a significant CAGR 3% during the forecast period (2022-2028). Tizanidine is a short-acting muscle relaxer that works by blocking nerve impulses (pain sensations) that are sent to the brain. Also available in the capsule form, the oral tablet of tizanidine is used to manage muscle spasms. The demand for the tizanidine drug is anticipated to grow owing to the growing prevalence of medical conditions such as multiple sclerosis, spastic diplegia, amyotrophic lateral sclerosis (ALS), back pain, and certain other injuries to the spine or central nervous system. Moreover, the drug is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. In some cases, it is also prescribed for the symptoms of fibromyalgia. Thus, the growing cases of migraine, sleep related disorders, convulsions, and fibromyalgia are anticipated to augment the demand for tizanidine, thereby augmenting the global tizanidine market growth.

In addition to this, the drug is also prescribed for the treatment of spasticity that temporarily relaxes the muscle tone. It is often used for people with multiple sclerosis, spinal cord injury, or muscle spasticity. Other driving factors of the global tizanidine market include the rising prevalence of chronic musculoskeletal diseases, and the launch of biosimilars. Further the availability of generic drug version of tizanidine is also likely to drive the market growth across the globe. Some key players operating in the market include Teva Pharmaceutical Industries Ltd., Novartis International AG, and Actavis Pharma, Inc., among others.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Type
• By Application

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: Teva Pharmaceutical Industries Ltd., Novartis International AG, and Actavis Pharma, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Tizanidine Market Report by Segment

By Type

• 2 mg
• 4 mg

By Application

• Kids
• Adults

Global Tizanidine Market Report by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa